Medical University of Lublin
73
7
8
44
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 73 trials
100.0%
+13.5% vs industry average
18%
13 trials in Phase 3/4
0%
0 of 44 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (73)
Lumbar ESPB in Hip Replacement Surgery
Role: lead
Updated Abdominal Compartment Society Consensus Definitions
Role: lead
Mirabegron in Patients With Age-Related Macular Degeneration
Role: collaborator
The Efficiency of Transcranial Direct Current Stimulation in the Treatment of Anorexia Nervosa
Role: lead
Validation of the FIGO Nutrition Checklist in Pregnant Women
Role: lead
Perfusion Related Evaluation of Systemic and Renal Vulnerability to Events in CABG
Role: lead
Xanthohumol as an Adjuvant in the Treatment of Septic Shock
Role: lead
Xanthohumol as an Adjuvant Therapy in Critically Ill COVID-19 Patients
Role: lead
Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients
Role: lead
GATT Versus Canaloplasty (GVC)
Role: collaborator
Cerebrolysin in Critically Ill Patients With Delirium
Role: lead
Diluted and Undiluted Enteral Nutrition
Role: lead
Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis
Role: lead
Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery
Role: lead
Pharmacokinetics of Meropenem During High-dose CRRT
Role: lead
Postoperative Analgesia After Minithoracotomy
Role: lead
Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients
Role: lead
TAP vs QLB in Patients After Cesarean Delivery
Role: lead
QLB After Nephrectomy
Role: lead
Pharmacokinetics of Caspofungin
Role: lead